Study objectives: This study examined whether obstructive sleep apnoea syndrome (OSAS) is associated with increased risk of work disability during six years following the diagnosis. Design: Prospective follow-up study. Setting: Ten municipalities and six hospital districts in Finland. Participants: A total of 766 employees with OSAS (cases), and their control subjects (n Z 3,827) matched for age, gender, socioeconomic position, type of employment contract and type of organization. Interventions: N/A. Measurements: Data on all (>9 days) or very long-term (>90 days) sickness absences and for disability pensions were obtained from national registers. Diagnosis of OSAS was determined according to the Hospital Discharge Register, which includes data on all hospital admissions. Results: According to the Cox proportional hazards models the hazard of the first sickness absence period (all sickness absences) during the follow-up was 1.7-fold (95% confidence interval (CI): 1.5e2.0) in male and 2.1-fold (95% CI: 1.8e2.4) in female sleep apnoea cases compared to controls after adjustments for sociodemographic factors. Both men and women with OSAS had a 2-fold increase in the risk for disability pension compared to controls. With regard to cause-specific work disability, employees with OSAS had a particularly pronounced risk of long-term work disability caused by injuries (HR 3.1 95% CI: 1.8e5.2) and mental disorders (HR: 2.8, CI 95%: 2.1e3.7). Conclusions: These results suggest that OSAS is associated with an increased risk of both sickness absence and disability pension. They emphasize the need to identify the employees with this disorder and to improve general practitioners' knowledge about screening of sleep apnoea symptoms and indicators. ª
Obstructive sleep apnoea syndrome (OSAS) is characterised by recurrent complete or partial respiratory interruptions during sleep, intermittent snoring, morning headaches, and daytime sleepiness. 1 It is a relatively common disorder, with the prevalence estimates varying from 2% to 10% 2e5 depending on the diagnostic criteria and the age of the population (the risk of OSAS increases with age). 3, 6 OSAS is associated with an increased risk of major cardiovascular, 7e9 psychiatric 10 and metabolic 11, 12 morbidity and increased mortality, 13e15 especially when untreated. 13 The economic and health care consequences of OSAS are considerable. 16, 17 In the USA, for example, the estimated health-related costs for untreated OSAS extend to US$ 3.4 billion per year. 18 When appropriately treated, the costs may be significantly reduced, even though they often still remain at a higher level than in the general population. 19 Although OSAS affects particularly working age population, 20 the consequences of the disorder in terms of temporary and permanent work disability are not well understood. Previously, OSAS or symptoms of sleep apnoea have been associated with an increased risk of occupational accidents, 21, 22 decreased working ability and lower work efficacy. 23, 24 In addition, people with OSAS have been found to have more health care visits compared to controls 5,16,18,25e28 already years before the diagnosis. 8, 26, 27 In a recent study, self-reported symptoms of sleep apnoea predicted long-term sick leave and permanent disability. 29 However, we are not aware of any previous studies examining the risk of work disability in terms of sickness absenteeism and work disability pension among persons with a diagnosed OSAS.
The purpose of this register-based follow-up study was to examine the association of diagnosed OSAS with subsequent medically certified sickness absence and disability pension from all and specific causes among Finnish public sector employees. Due to major comorbidity linked with OSAS, chronic diseases such as cardiovascular diseases, diabetes, asthma or other chronic obstructive lung diseases and depression were taken into account in the analyses.
Methods

Study population and design
The data were obtained from the Finnish Public Sector Study, which is an ongoing prospective cohort study of Finnish employees in the service of six hospital districts and 10 municipalities. 30 For this study, we identified the eligible population from the employers' records, i.e., 151,618 public sector employees who had been employed for at least six months in any year between 1991 and 2005. Sickness absence and disability pension data from national registers cover the period between 1994 and 2005. To enable post-diagnosis follow-up for each participant, only the persons getting an OSAS diagnosis between 1994 and 2004 were initially included (n Z 1073). Of these, persons who were 63 years or older (n Z 68), had died (n Z 6), were granted disability pension within the year subsequent to the OSAS diagnosis (n Z 163), or were not employed by the participating organizations within 3 years prior to the diagnosis (n Z 70) were excluded leaving 766 cases in the analytic sample.
Five controls, matched for gender, age category (20e44, 45e54 or 55e62), socioeconomic position (SEP), type of employment contract (permanent or fixed term) and type of organization (hospital district or municipality), were randomly selected for each sleep apnoea case from the public sector employees not diagnosed with OSAS. For one sleep apnoea case, only three control subjects fulfilling all the predetermined criteria was found, so the final cohort consisted of 766 employees with OSAS and 3827 controls.
The approval of the ethics committee of the Finnish Institute of Occupational Health was obtained for the study.
Assessment of obstructive sleep apnoea syndrome
The participants' personal identification numbers (a unique number assigned to each Finnish citizen used for all contacts with the social welfare and health care systems) were used to link the participants to the national Hospital Discharge Register kept by the National Research and Development Centre for Health and Welfare (STAKES). The Hospital Discharge Register gathers countrywide data on all inpatient hospital admissions. For this study, we obtained the admission dates for hospitalisation and diagnosis at discharge. For all cases, OSAS was assigned by the treating physician (codes 3472A and G47.3 in ICD-9 and ICD-10, 
Assessment of sociodemographic and clinical characteristics
The following sociodemographic characteristics were derived from the employers' records: gender, age, SEP based on occupational title-based classification of Statistics Finland, i.e., upper-grade non-manual workers (e.g., physicians, teachers), lower-grade non-manual workers (e.g., technicians, registered nurses), and manual workers (e.g., cleaners, maintenance workers), type of employment contract (permanent or fixed term) and type of organization (municipality or hospital district).
The following comorbid conditions prevalent during the year of the diagnosis of OSAS (i.e., 1994e2004) were considered in this study: hypertension, ischemic heart disease, diabetes, asthma or other chronic obstructive lung disease and depression. In Finland, the national sickness insurance scheme covers all permanent residents of the country, regardless of sex, age or occupational title, and provides at present basic reimbursement of 42% for all filled prescriptions and special reimbursement of 72% or 100% for many chronic and severe diseases. Patients who apply for special reimbursement must attach a detailed medical certificate prepared by the treating physician, who also provides data to confirm the diagnosis. This is further checked by a physician at the Social Insurance Institution who reviews each case history. We extracted data on entitlements of special reimbursements, i.e., rights to receive higher than basic compensation for medication costs of a serious chronic disease from the Drug Reimbursement Register, kept by the Social Insurance Institution of Finland for hypertension, ischemic heart disease, diabetes and asthma or other chronic obstructive lung disease.
The presence of depression was determined by the use of antidepressants. Data on the purchase of antidepressants was derived from the Drug Prescription Register, which comprises out-patient medication purchases classified according to the World Health Organization's Anatomical Therapeutic Chemical classification code. 32 All the antidepressant purchases (ATC code N06A) and corresponding defined daily doses (DDD) between 1994 and 2004 were extracted. Persons purchasing at least 100 DDD per year at baseline were considered as having depression.
Outcome measures
Sickness absences Data on sickness absences and related diagnoses were obtained from the sickness absence register of the Social Insurance Institution of Finland. All permanent residents aged 16e67 years in Finland are entitled to daily allowances due to a sick leave based on a medical certificate after a waiting period of nine days, in addition to the first day of illness, for a period of 1 year at the most. If the employer pays the salary during the sick leave, the reimbursement is given to the employer. The information retrieved from the national register for this study covers the dates of all reimbursed sickness absences during 1994 and 2005.
For sick leaves lasting 90 days, the main diagnoses were additionally retrieved. Four main disease categories were used in this study: mental and behavioural diseases (International Classification of Diseases, ICD-10: F00-F99); diseases of circulatory system, (I00-I99); diseases of the musculoskeletal system and connective tissue (M00-M99); and injury, poisoning or other consequences of external cause, (S00-T98). Diagnoses for sick leaves lasting 90 days have been recorded for all cases from year 1997 onward, but before that the information is available only for 10% random sample of the population.
Disability pension
Data on work disability pension were obtained from the Finnish Centre for Pensions, which provides a complete retirement data as it grants pensions for all permanent residents in Finland. The dates and underlying causes (according to the ICD-10) of early retirement were obtained from medical certificates for all participants granted a full disability pension between 1994 and 2005.
Statistical analyses
Since health care utilization has been shown to increase when approaching the time of the OSAS diagnosis, 26 we included a one year post-diagnosis ''wash-out'' period and started the follow-up 365 days after the date of diagnosis for each OSAS case and at the same time for the corresponding controls. The follow-up ceased at the end of 2005 or on the date of sickness absence or disability pension was granted, or the person died or reached the age of 63 years (statutory age of retirement). The mean time at risk was 5.9 (SD 3.0) years and 5.8 (SD 3.0) years for cases and controls, respectively.
Cox proportional hazards models were used to estimate the relative risk of the first work disability event between cases and controls separately for men and women. The time-dependent interaction between OSAS and follow-up period was statistically non-significant confirming that the proportional hazards assumption was justified. 33 The outcome variables were first sickness absence (>9 days), first very long sickness absence (90 days), first full-time disability pension and cause-specific work disability. For the last outcome, very long sickness absences and disability pension were considered together due to a fairly low number of events in different diagnostic groups. Hazard ratios (HR) and their 95% confidence intervals (CI) were always adjusted for sociodemographic factors (age, gender, SEP, type of employment contract and type of organization), and additionally for the presence of baseline medical conditions (chronic hypertension, ischemic heart disease, diabetes, chronic asthma or other chronic obstructive lung disease and depression). To further clarify the importance of different comorbidities associated with OSAS as predictors of future sickness absence or disability pension, we divided the population into subgroups according to the presence of major diseases associated with OSAS, i.e., cardiovascular diseases or diabetes, asthma or other chronic obstructive lung diseases and depression at baseline.
All statistical analyses were carried out using the SAS 9.1.3 programme package (SAS Institute Inc., Cary, NC, USA).
Results
A total of 766 cases (59.5% men) fulfilling all the predetermined inclusion criteria were detected from the Hospital Discharge Register during 1994e2004. Baseline characteristics of the employees with sleep apnoea (cases) and their corresponding controls (n Z 3827) are shown in Table 1 . Sociodemographic characteristics did not differ between the groups indicating the success of matching. As expected, employees with OSAS had more comorbid medical conditions than the controls. For example, 23.4% of the cases had chronic hypertension, 8.6% chronic asthma or other obstructive lung disease and 9.8% had depression.
The corresponding figures for controls were 10.2%, 3.0% and 2.2%, respectively. In total 38.8% of the sleep apnoea patients had at least one comorbid condition, compared to 16.4% of controls.
Association between OSAS and sickness absences Table 2 shows the associations between OSAS and all or very long sickness absences by gender. For both outcomes, OSAS was associated with an increased risk of sickness absences in men and women and the risk was only partly attributable to comorbidities. The hazard of the first sickness absence period during the follow-up was 1.7e1.9 times higher for male and 2.1e2.0 times higher in female sleep apnoea cases compared to controls when adjusted for sociodemographic factors. The hazard ratios were similar for very long-term sickness absences. After further adjustments for different comorbidities the hazard ratios attenuated by 9.9%e21.6% in men and 12.4%e23.1% in women. Differences between cases and controls in categorical variables were tested by Chi-Square (c 2 ) test. a Granted special reimbursement for chronic hypertension, ischemic heart disease, diabetes, asthma or other chronic obstructive lung disease or purchase of antidepressants ( ‡100 DDDs/year) according to the register of the Social Insurance Institution of Finland.
b DDD Z defined daily dose.
Association between OSAS and disability pension
There was also a statistically significant association between OSAS and full-time disability pension ( Table 2 ). The Cox proportional hazards models adjusted for sociodemographic factors showed an approximately 2.2-and 2.7-fold increase in the risk for disability pension in men and women with OSAS, respectively. The estimates decreased in the fully adjusted model, however, still remaining approximately 2-folds in both genders.
Comorbidity Fig. 1 shows the percentage of employees who were granted a disability pension during the follow-up, by the status of comorbidity and coexisting OSAS. Persons with OSAS but no comorbidities and those with cardiovascular disease or diabetes and coexisting OSAS had an approximately 2-fold risk for subsequent disability pension compared to the corresponding control group with no OSAS. Further adjustments attenuated the hazard ratios by 15.4%e22.2%. Similar results were found with regard to sickness absences. Employees with OSAS but no comorbidities and those with cardiovascular disease, diabetes or asthma and coexisting OSAS had an increased risk for sickness absences compared to employees with no OSAS when adjusted for all covariates. Among persons with depression, no excess risk was found in terms of subsequent sickness absence or disability pension, but the number of cases was small.
Association between OSAS and cause-specific work disability Table 3 shows the results of the association between OSAS and a composite outcome of subsequent very long sickness absence and disability pension according to the major diagnostic categories. Employees with OSAS had an increased risk of work disability in all diagnostic categories, but a particularly high risk for work disability caused by different injuries and mental disorders (HR in the fully adjusted model 3.1, 95% CI: 1.8e5.2 and 2.8, 95% CI: 2.1e 3.7, respectively).
Discussion
In this large register-based study on Finnish public sector employees, OSAS was associated with a 1.7e2.7-fold excess risk of work disability in men and women during approximately six years after the OSAS diagnosis. These associations were observed for various indicators of work disability, including total sickness absence, long-term absence and disability pensions and they remained statistically significant after adjustments for comorbid medical conditions. Intriguingly, the risk was constantly more pronounced among women than among men. With regard to cause-specific work disability, employees with OSAS had a particularly high risk of work disability caused by different injuries and mental disorders.
Our study is among the first in directly assessing the risk of sickness absence and disability pension among persons with diagnosed OSAS. Recently self-reported symptoms of OSAS were also associated with long-term sickness leave and permanent work disability. 29 Since we were able to use properly diagnosed patients, our study is less prone to reporting bias. Therefore, it notably adds to the existing evidence on the association between sleep apnoea and No OSAS OSAS Figure 1 Risk of work disability by status of obstructive sleep apnoea syndrome (OSAS) and coexisting chronic diseases at baseline. The figure gives percentage of employees granted disability pension during the follow-up and corresponding hazard ratios and their 95% confidence intervals. Chronic diseases were defined according to the registers of the Social Insurance Institution of Finland. Adjusted for age gender, socioeconomic position, type of employment contract and type of organization. CVD Z cardiovascular diseases (hypertension, ischemic heart disease); DM Z diabetes mellitus; and asthma Z chronic asthma or other chronic obstructive lung disease. No. of cases and controls in each group: no depression n Z 691 and n Z 3742; depression n Z 75 and n Z 85; no CVD/DM n Z 565 and n Z 3370; CVD/DM n Z 201 and n Z 457; no asthma n Z 700 and n Z 3713; asthma n Z 66 and n Z 114, respectively. long-term work disability. Indirect evidence from previous studies is also consistent with our findings as OSAS or its symptoms have been associated with an increased risk for occupational and leisure time accidents 21, 34, 35 and an increased utilization of health care services, 16, 19 ,25e28 even 10 years before the actual diagnosis. 26 Also fatigue has predicted intermediate and long-term sickness absences in the general population. 36 In the present study, almost 40% of employees with OSAS also had some other chronic disease (cardiovascular disease, diabetes, asthma or other chronic obstructive lung disease or depression). Since such chronic diseases are major risk factors for work disability, 37e40 the excess risk of work disability related to OSAS could be attributable to these comorbid conditions. According to our results the hazard ratios of work disability attenuated by 9.9%e32.1% after adjustments for different comorbidities, but still remained at statistically significantly elevated levels compared to controls. The excess risk was thus only partly attributable to other severe and chronic diseases.
Patient group analyses provided further support for the status of OSAS as an independent risk factor of work disability. Among employees with medical comorbidity, coexisting OSAS was associated with an increased risk for subsequent sickness absences and disability pension. Although these results were based on a selective small number of cases, they indicate that OSAS per se increases the risk of work disability, even among persons with other severe and chronic diseases. Among employees with depression and coexisting OSAS, the risk estimates were notably lower and statistically non-significant. This may indicate that among employees with depression, OSAS does not predispose to any further risk of work disability.
However, we may have misclassified some depression cases, because antidepressant use as a proxy measure lacks sensitivity, i.e., cases without antidepressant treatment are not detected. In addition, depression per se is one of the major risk factors of very long work absenteeism 41, 42 and has often been linked to OSAS. 43 It has been suggested that among sleep apnoea patients depression could be considered as secondary to the medical disorder rather than a distinct psychiatric entity. 44 Prospective study design and large sample size are important strengths of this study. The data for this study were obtained from national registers, which are reliable and have high coverage. 45, 46 All medically certified longterm sickness absences were retrieved from the Social Insurance Institution of Finland, which is a responsible organ for execution of statutory health insurance covering basically all citizens residing in Finland. To detect sleep apnoea cases the national Hospital Discharge Register was used. The use of this kind of register information minimizes the risks of measurement and recall bias, often associated with self-reported measures. 47 There are, however, some limitations to be considered when interpreting the results of our study. First, some misclassification of OSAS is possible. Only persons who were discharged from hospital with the main diagnosis of OSAS according to the Hospital Discharge Register for the first time during 1994e2004 were included in this study as cases. Some kind of sleep registration was very likely during their stay, even though we were not able to verify this. Since all patients had spent at least one night in hospital, we assume that the cases included in this study are most probably ''certain'' cases, i.e., true sleep apnoea patients. We believe thus that our measure had a high specificity. In contrast, our measure may lack sensitivity; we were probably able to reach only the ''tip of the iceberg''. It is estimated that even one in five adults has asymptomatic or nearly asymptomatic sleep apnoea 5 and many of these remain undiagnosed. 48, 49 However, in the present study the effect of false negatives is diluted into a large amount of healthy controls, and do not thus bias the results. Furthermore, misclassification due to false negatives is likely to cause a large bias in estimation only if the prevalence of the disease is high and the effect very large. In the present study, a roughly estimated lifetime prevalence of OSAS was 0.5% among female and 2.2% among male employees in our cohort. These estimates are close to the Finnish national estimates discovered in the Health 2000 survey, where the prevalence of diagnosed OSAS was 0.4% in women, 2.4% in men. 50 Second, Body Mass Index (BMI) could not be taken into account in matching or in the analyses due to unavailability of this data from registers. High BMI has predicted temporary and long-term work disability 51, 52 and obesity has been shown to predispose people with OSAS to higher health service utilization. 26 However, in our sample only 19 participants had a diagnosis of obesity suggesting that overweight, at least in its severest form, was not common. In addition, we were unable to control for stressful work characteristics, such as long working hours, high work load and low job control, which have previously been associated with disability pension. 53 Third, we do not know, whether our participants with OSAS were effectively treated after the diagnosis or not, and whether they adhered to the treatment if determined. Previously, treatment of OSAS with continuous positive airway pressure (CPAP) has reduced health care utilization and costs during five years after the diagnosis. 27 The effect of different treatment modalities on temporary and permanent work disability should be considered in further studies.
Finally, this is a prospective follow-up study of public sector employees and is, therefore, not representative of the Finnish working population, which potentially limits the generalisability of our findings.
In conclusion, our results indicate that OSAS may seriously deteriorate working ability by increasing the risk of both sickness absences and full-time disability pension among employees with OSAS. These results emphasize the need to identify the employees with this disorder and to improve general practitioners' knowledge about screening of OSAS symptoms and indicators.
